Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion type Assertion NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_head.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion description "[Our analysis further reveals that clinical resistance to these drugs may be attenuated by using multitargeted inhibitors that simultaneously inhibit additional PI3K pathway members.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_provenance.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion evidence source_evidence_literature NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_provenance.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion SIO_000772 18691552 NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_provenance.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion wasDerivedFrom befree-20150227 NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_provenance.
- NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_assertion wasGeneratedBy ECO_0000203 NP625444.RAX2fft7_6O32H3QgxcqpluvmATVof6GYo8eRp0pcbSPE130_provenance.